ReviewClinical pharmacokinetics2005

Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism.

Bertrand RochatPubMed ↗Publisher ↗

No numbers read from the abstract.